RT Journal Article
SR Electronic
T1 The aerobiology of SARS-CoV-2 in UK hospitals and the impact of aerosol generating procedures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.07.22279662
DO 10.1101/2022.09.07.22279662
A1 Gould, Susan
A1 Byrne, Rachel L
A1 Edwards, Thomas
A1 Aljayyoussi, Ghaith
A1 Wooding, Dominic
A1 Buist, Kate
A1 Kontogianni, Konstantina
A1 Bennett, Allan
A1 Atkinson, Barry
A1 Moore, Ginny
A1 Dunning, Jake
A1 Todd, Stacy
A1 Hoyle, Marie-Claire
A1 Turtle, Lance
A1 Solomon, Tom
A1 Fitzgerald, Richard
A1 Beadsworth, Mike
A1 Garner, Paul
A1 Adams, Emily R
A1 Fletcher, Tom
YR 2022
UL http://medrxiv.org/content/early/2022/09/16/2022.09.07.22279662.abstract
AB Background SARS-CoV-2 nosocomial transmission to patients and healthcare workers (HCWs) has occurred throughout the COVID-19 pandemic. Aerosol generating procedures (AGPs) seemed particularly risky, and policies have restricted their use in all settings. We examined the prevalence of aerosolized SARS-CoV-2 in the rooms of COVID-19 patients requiring AGP or supplemental oxygen compared to those on room air.Methods Samples were collected prospectively near to adults hospitalised with COVID-19 at two tertiary care hospitals in the UK from November 2020 – October 2021. The Sartorius MD8 AirPort air sampler was used to collect air samples at a minimum distance of 1.5 meters from patients. RT-qPCR was used following overnight incubation of membranes in culture media and extraction.Results We collected 219 samples from patients’ rooms: individuals on room air (n=67), receiving oxygen (n=65) or AGP (n=67). Of these, 54 (24.6%) samples were positive for SARS-CoV-2 viral RNA. The highest prevalence was identified in the air around patients receiving oxygen (32.3%, n=21, CI95% 22.2 to 44.3%) with AGP and room air recording prevalence of (20.7%, n=18, CI95% 14.1 – 33.7%) and (22.3%, n=15, CI95% 13.5 – 30.4%) respectively. We did not detect a significant difference in the observed frequency of viral RNA between interventions.Interpretation SARS-CoV-2 viral RNA was detected in the air of hospital rooms of COVID-19 patients, and AGPs did not appear to impact the likelihood of viral RNA. Enhanced respiratory protection and appropriate infection prevention and control measures are required to be fully and carefully implemented for all COVID-19 patients to reduce risk of aerosol transmission.Competing Interest StatementEmily Adams is Director of Epidemics and NTDs at Global Access diagnostics.Funding StatementSG, EA, JD, LT, TS and TF are supported by the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections. SG and PG are supported by the READ‐It (project number 300342‐104) which is funded by UK aid from the UK government. PhD stipend from the medical research council to RLB.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the corresponding author.